Enfortumab vedotin-ejfv (ADC)
Gecertificeerd

Enfortumab vedotin-ejfv (ADC)

Catalog #: DHJ41099
Maat: 5 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE), suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.

Product Name Alternative

Padcev, ASG-22ME

Reactivity

Human

Applications

Research Grade Biosimilar

Stability

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.

Endotoxin

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Form

Liquid

Notes

For research use only. Not suitable for clinical or therapeutic use.

Beschrijving

Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE), suitable for adult patients with locally advanc

Specificaties

ProductnaamEnfortumab vedotin-ejfv (ADC)
Categorie
Beschikbare grootte5 mg
CatalogusnummerDHJ41099